Looking at existing data on the expression of VHL and its correlation with clinicopathological features in other cancer types, Zia et al. [89] reported that in highly aggressive breast cancer cell lines, VHL was either not expressed or was expressed at a low level, affecting cell motility and invasiveness. This evidence concerns the gene VHL and breast cancer.